Author:
Cooper Thomas B.,Harrison Wilma M.,Stewart Jonathan W.,Klein Donald F.
Reference12 articles.
1. Bonham Carter, S., Karoum, F., Sandler, M., and Youdim, M.B.H. (1970) The effect of tyramine on phenolic acid and alcohol excretion in man. Br. J. Pharmacol. 39, 202P.
2. Bonham Carter, S.M., Sandler, M., Goodwin, B.L., Sepping, P., and Bridges, P.K. (1978) Decreased urinary output of tyramine and its metabolites in depression. Br. J. Psychiat. 132, 125–132.
3. Bonham Carter, S.M., Reveley, M.A., Sandler, M., Dewhurst, J., Little, B.C., Hayworth, J. and Priest, R.G. (1980) Decreased urinary output of conjugated tyramine is associated with lifetime vulnerability to depressive illness. Psychiat. Res. 3, 13–31.
4. Bonham Carter, S.M., Glover, V., Sandler, M., Gillman, P.K. and Bridges, P.K. (1981) Human platelet phenol-sulphotransferase: separate control of the two forms and activity range. Clin.Chim.Acta 117, 333–344.
5. Cloninger, CR., vonKnorring, L. and Oreland, L. (1985) Pentametric distribution of platelet monoamine oxidase activity. Psychiat. Res. 15, 133–143.